Mark A. Feitelson
Temple University, USA
Biography
Mark Feitelson received his BS in biology from the UCI in 1974. He was a graduate student in the Department of Microbiology and Immunology at the UCLA School of Medicine, where he began is studies of viral oncogenesis, and received a Ph.D. degree in 1979. He was then an American Cancer Society Postdoctoral Fellow in the Department of Medicine at Stanford University from 1979-1982. Dr. Feitelson then moved to the Fox Chase Cancer Center in Philadelphia, where he studied the biology of hepatitis B virus (HBV) with Dr. Baruch S. Blumberg, who won the Nobel Prize in medicine (1976) for his discovery of HBV. In 1991, Feitelson moved to the Department of Pathology and Cell Biology at Thomas Jefferson University where he became a full professor. In 2007, Dr. Feitelson moved to Temple University, where he is a full-professor with tenure. He is also currently the Chair of the Professional Science Master’s program in Biotechnology at Temple. His lab has produced more than 130 publications, which include two books, several book chapters, and numerous invited reviews. Since the early 1980’s, Dr. Feitelson has been interested in the pathogenesis of chronic hepatitis B virus infection. His lab has uncovered critical steps whereby the HBV encoded X antigen, HBx, contributes to the pathogenesis of chronic liver disease and the development of hepatocelular carcinoma (HCC).
Abstract
Abstract : Identification of Early Drivers of HBV associated Hepatocarcinogenesis
